Latest Anocca News & Updates

See the latest news and media coverage for Anocca. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Anocca

Biotechnology company developing precision T-cell immunotherapies

anocca.com
Headquarters
Södertälje, Sweden
Founded year
2014
Company type
Private company
Number of employees
120–200
Industry
Pharmaceuticals

Last updated

Latest news about Anocca

In short: Anocca dosed the first patient in Sweden with its ANOC-001 TCR-T therapy for pancreatic cancer

Company announcements

Anocca

Anocca secures EUR 25 million from the European Investment Bank

The venture debt will support clinical development of its next-generation T-cell therapies for cancer, targeting a solid tumour indication by 2024.

Unlock all announcements with a

Media coverage

The Manila Times

Anocca Announces Authorisation of Clinical Trial Application to Start First In-Human Trial in Advanced Pancreatic Cancer

CTA approval marks Anocca's transition to a clinical-stage company First-in-human VIDAR-1 trial begins with the deployment of ANOC-001 in Advanced Pancreatic Cancer at leading medical...

Unlock all articles with a

Never miss news about Anocca

Track Anocca and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.